home / stock / atha / atha quote
Last: | $2.04 |
---|---|
Change Percent: | 1.44% |
Open: | $2.06 |
Close: | $2.04 |
High: | $2.13 |
Low: | $2.03 |
Volume: | 84,796 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.04 | $2.06 | $2.04 | $2.13 | $2.03 | 84,796 | 04-23-2024 |
$2.09 | $2.17 | $2.09 | $2.17 | $2.075 | 128,081 | 04-22-2024 |
$2.13 | $2.06 | $2.13 | $2.1601 | $2.06 | 203,913 | 04-19-2024 |
$2.06 | $2.11 | $2.06 | $2.2 | $2.021 | 198,077 | 04-18-2024 |
$2.11 | $2.16 | $2.11 | $2.26 | $2.11 | 111,525 | 04-17-2024 |
$2.11 | $2.06 | $2.11 | $2.21 | $2.06 | 165,036 | 04-16-2024 |
$2.06 | $2.44 | $2.06 | $2.485 | $2.022 | 373,924 | 04-15-2024 |
$2.44 | $2.6 | $2.44 | $2.66 | $2.41 | 160,015 | 04-12-2024 |
$2.65 | $2.57 | $2.65 | $2.725 | $2.555 | 258,198 | 04-11-2024 |
$2.48 | $2.45 | $2.48 | $2.51 | $2.418 | 139,936 | 04-10-2024 |
$2.52 | $2.43 | $2.52 | $2.56 | $2.4139 | 179,862 | 04-09-2024 |
$2.42 | $2.49 | $2.42 | $2.49 | $2.39 | 144,347 | 04-08-2024 |
$2.47 | $2.49 | $2.47 | $2.57 | $2.4399 | 176,255 | 04-05-2024 |
$2.5 | $2.53 | $2.5 | $2.661 | $2.484 | 225,686 | 04-04-2024 |
$2.5 | $2.45 | $2.5 | $2.55 | $2.385 | 208,456 | 04-03-2024 |
$2.48 | $2.51 | $2.48 | $2.58 | $2.42 | 222,286 | 04-02-2024 |
$2.51 | $2.71 | $2.51 | $2.71 | $2.5 | 422,742 | 04-01-2024 |
$2.74 | $2.59 | $2.74 | $2.825 | $2.55 | 578,370 | 03-29-2024 |
$2.74 | $2.59 | $2.74 | $2.825 | $2.55 | 578,370 | 03-28-2024 |
$2.56 | $2.58 | $2.56 | $2.715 | $2.56 | 217,878 | 03-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Athira Pharma Inc. Company Name:
ATHA Stock Symbol:
NASDAQ Market:
BOTHELL, Wash., April 15, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused o...
BOTHELL, Wash., April 15, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the appointment of Javier San Martin, M.D., as Ch...
BOTHELL, Wash., April 11, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the publication of preclinical data supporting th...